| | | | | | | |
 | MODERNA, INC. | -2.66% | -10.52% | -1.98% | 3.97% | 758.41% | 67 639 |
| IQVIA HOLDINGS INC. | 1.38% | 1.61% | 11.97% | -6.33% | 47.77% | 42 611 |
 | LONZA GROUP AG | 1.35% | 6.96% | 16.22% | -17.51% | 32.48% | 42 044 |
| ALNYLAM PHARMACEUTICALS, INC. | 0.44% | -2.25% | -4.73% | 64.53% | 97.23% | 27 854 |
| SEAGEN INC. | -0.36% | 1.92% | 8.54% | 3.69% | 28.68% | 25 897 |
| ICON PUBLIC LIMITED COMPANY | 3.00% | -0.48% | 18.77% | -13.18% | 36.82% | 18 836 |
 | CELLTRION, INC. | -1.28% | -1.76% | 0.69% | 11.30% | 5.97% | 18 775 |
 | HANGZHOU TIGERMED CONSULTING CO., LTD. | -2.42% | -0.96% | 10.97% | 12.62% | 58.75% | 14 384 |
| BIO-TECHNE CORPORATION | 1.25% | -4.39% | -3.89% | -15.35% | 51.76% | 12 504 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 1.45% | -1.22% | 11.63% | -26.23% | 57.36% | 12 376 |
| PHARMARON BEIJING CO., LTD. | -9.29% | -4.91% | 9.12% | -5.87% | 89.93% | 12 349 |
| UNITED THERAPEUTICS CORPORATION | 1.72% | 1.06% | -5.37% | 30.37% | 169.45% | 11 994 |
| QIAGEN N.V. | 0.37% | -3.52% | -1.74% | -0.99% | 45.06% | 11 157 |
 | GENSCRIPT BIOTECH CORPORATION | 6.62% | -4.51% | 13.48% | 14.87% | 53.76% | 7 137 |
| MEDPACE HOLDINGS, INC. | 2.90% | -10.30% | 4.08% | 24.57% | 158.41% | 6 857 |
| | | | | | | |
| | Moyenne | 0.30% | -2.22% | 5.85% | 5.37% | 112.79% | |
| | Moyenne pondérée par Capi. | -0.16% | -2.04% | 5.78% | 4.03% | 199.37% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
